Remifentanil supply disruption update

GlaxoSmithKline Australia has advised that new stock of Ultiva (remifentanil hydrochloride) will be unavailable in Australia and potentially NZ until 2018.
 
For more information see here
Copyright © Australian and New Zealand College of Anaesthetists.